☆ 4.5 Letter

Multidrug-resistant Streptococcus pneumoniae in young children

LANCET MICROBE (2023)

Related references

Note: Only part of the references are listed.
Article Medical Laboratory Technology

Serotype Distribution and Antimicrobial Resistance of Streptococcus pneumoniae Causing Invasive Pneumococcal Disease in Korea Between 2017 and 2019 After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine

Gyu Ri Kim et al.

Summary: After the introduction of PCV13 in Korea, there have been changes in the serotype distribution and antimicrobial resistance of invasive S. pneumoniae causing IPD. Non-PCV13 serotypes are increasing, and there are differences in antimicrobial resistance according to specific serotypes. Continuous monitoring of serotypes and antimicrobial resistance is crucial for the appropriate management of S. pneumoniae infections.

ANNALS OF LABORATORY MEDICINE (2023)

Add to Collection
Article Infectious Diseases

Emergence of a multidrug-resistant and virulent Streptococcus pneumoniae lineage mediates serotype replacement after PCV13: an international whole-genome sequencing study

Stephanie W. Lo et al.

Summary: The study found that the increase in the 24F serotype globally is mainly due to the clonal spread of three lineages, with GPSC10 (CC230) being the only multidrug-resistant lineage driving the increase in France. Spatial-temporal analysis revealed that it took 3-5 years for GPSC10-24F to spread across France, and a rapid change in serotype composition was observed in neighboring countries during the introduction of PCV13.

LANCET MICROBE (2022)

Add to Collection
Article Infectious Diseases

Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004-20: a national surveillance study

Julio Sempere et al.

Summary: The study reveals a decline in serotypes included in PCV7 and PCV13 after their introduction in Spain, but an increase in non-PCV13 serotypes (mainly 11A, 24F, and 23B) that are not susceptible to PCV13, posing a threat to antibiotic resistance. An increase in pneumococcal strains with reduced susceptibility to 13-lactams and erythromycin was observed in 2020, coinciding with the emergence of SARS-CoV-2.

LANCET MICROBE (2022)

Add to Collection
Article Infectious Diseases

Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance study

Naim Ouldali et al.

Summary: The implementation of PCV13 in France led to a significant reduction in the incidence of invasive pneumococcal disease, but a rebound in cases among children and adults since 2015, driven by several emerging non-PCV13 serotypes, jeopardizes the long-term benefits of PCV.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection
Article Biotechnology & Applied Microbiology

Serotype distribution and clinical characteristics associated withstreptococcus pneumoniaeamong Chinese children and adults with invasive pneumococcal disease: a multicenter observational study

Ma-Chao Li et al.

Summary: The study revealed that non-PCV7 serotypes 19A and 3 were the most prevalent in Chinese children and adults, respectively. High-valent vaccines showed similar coverage rates and may have a greater potential in preventing IPD.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.